IRWD
IRONWOOD PHARMACEUTICALS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$4.36
+3.07%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- $0.30
- Revenue estimate
- $120.0M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.31
- EPS estimate
- $0.32
- Revenue actual
- $113.0M
- Revenue estimate
- $114.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +214.9%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.32 | $0.31 | Miss -3.13% | $113.0M |
| May 7, 2026 | $0.07 | $0.24 | Beat 242.86% | $106.5M |
| Aug 7, 2025 | -$0.02 | $0.14 | Beat 800.00% | $85.2M |
| May 7, 2025 | -$0.05 | -$0.14 | Miss -180.00% | $41.1M |
| Feb 27, 2025 | $0.10 | $0.02 | Miss -80.00% | $90.5M |
| Nov 7, 2024 | $0.08 | $0.02 | Miss -75.00% | $91.6M |
| Aug 8, 2024 | $0.15 | -$0.01 | Miss -103.61% | $94.4M |
| May 9, 2024 | $0.18 | -$0.02 | Miss -111.11% | $74.9M |
| Feb 15, 2024 | $0.21 | -$0.01 | Miss -104.76% | $117.6M |
| Nov 9, 2023 | $0.16 | $0.09 | Miss -43.75% | $113.7M |
| May 4, 2023 | $0.24 | $0.25 | Beat 4.60% | $104.1M |
| Feb 16, 2023 | $0.27 | $0.27 | Beat 0.37% | $107.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026